Carregant...
Antiviral Therapies and Prospects for a Cure of Chronic Hepatitis B
Current therapies of chronic hepatitis B (CHB) remain limited to either pegylated interferon-α (Peg-IFN-α), or one of the five approved nucleoside analog (NA) treatments. Although viral suppression can be achieved in the majority of patients with high-barrier-to-resistance new-generation NAs (i.e.,...
Guardat en:
| Publicat a: | Cold Spring Harb Perspect Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cold Spring Harbor Laboratory Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382723/ https://ncbi.nlm.nih.gov/pubmed/25833942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a021501 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|